GNH USA

Europe — EMA

Levodopa+carbidopa+entacapone Mylan

GNH USA supplies Levodopa+carbidopa+entacapone Mylan (Levodopa/Carbidopa/Entacapone), a combination dopamine precursor and COMT inhibitor for Parkinson's

Entacapone, Levodopa, Carbidopa Monohydrate

Request sourcing

1
Pack/s

What is Entacapone, Levodopa, Carbidopa Monohydrate?

Levodopa, carbidopa, and entacapone, the active ingredient in Levodopa+carbidopa+entacapone Mylan, is a combination dopamine precursor and COMT inhibitor presented as an oral tablet for oral use. It treats Parkinson's disease in adults by improving motor control and reducing OFF periods.

GNH USA supplies Levodopa+carbidopa+entacapone Mylan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Entacapone, Levodopa, Carbidopa Monohydrate used for?

Levodopa/Carbidopa/Entacapone is indicated for Parkinson's disease and related motor complications. It works within the dopaminergic pathway to enhance symptom control. - Parkinson's disease (early stage): improves overall motor function and reduces rigidity. - Parkinson's disease with motor fluctuations: shortens OFF time and stabilises response to levodopa. - Advanced Parkinson's disease: enhances the effectiveness of levodopa therapy and helps maintain daily activities.

What are the side effects of Entacapone, Levodopa, Carbidopa Monohydrate?

Levodopa+carbidopa+entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea - Dizziness or light‑headedness - Orthostatic hypotension - Insomnia or vivid dreams - Dyskinesia (involuntary movements) - Diarrhoea or abdominal discomfort

Serious or Rare Side Effects: - Severe liver injury or hepatitis - Neuroleptic malignant syndrome - Anaphylaxis or severe allergic reactions - Marked depression, suicidal thoughts, or psychosis - Hematologic abnormalities such as neutropenia - Hyperuricemia leading to gout attacks

What precautions apply to Entacapone, Levodopa, Carbidopa Monohydrate?

When prescribing Levodopa+carbidopa+entacapone, clinicians should consider several safety factors. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic disease: use with caution; assess liver enzymes regularly. - Cardiovascular disease: observe blood pressure for orthostatic changes. - Psychiatric history: watch for mood swings, depression, or hallucinations. - Concomitant MAO‑B inhibitors: avoid combined use due to risk of hypertensive crisis. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

What does Entacapone, Levodopa, Carbidopa Monohydrate interact with?

Levodopa+carbidopa+entacapone can interact with several drug classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Anticholinergic agents: may worsen confusion or cognitive impairment. - Certain antidepressants (SSRIs, SNRIs): increased risk of serotonin syndrome. - Iron or aluminium-containing supplements: reduce levodopa absorption. - Typical antipsychotics (e.g., haloperidol): antagonise dopamine effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask orthostatic hypotension. - Diuretics: can affect electrolyte balance. - CNS depressants: may enhance sedation. - CYP2C9 inhibitors: may raise entacapone plasma levels. - High‑protein meals: can diminish levodopa efficacy, requiring timing adjustments.

Frequently asked questions

What is Levodopa+carbidopa+entacapone used for?+
Levodopa+carbidopa+entacapone is a fixed‑dose combination used to manage Parkinson's disease. It improves motor symptoms, reduces the frequency of OFF periods, and helps maintain a more stable response to levodopa therapy in adults.
How does Levodopa/Carbidopa/Entacapone work?+
Levodopa is converted to dopamine in the brain, restoring deficient neurotransmission. Carbidopa blocks peripheral conversion of levodopa, increasing its availability to the central nervous system. Entacapone inhibits the COMT enzyme, slowing levodopa breakdown and extending its plasma half‑life, which together provide smoother dopaminergic stimulation.
What is the usual dose of this medication?+
The dosage regimen is individualized and set by the prescribing clinician based on disease severity, response, and tolerability. Typical treatment involves multiple tablets taken several times daily, but exact strength, frequency, and timing are determined by the healthcare professional.
Is Levodopa+carbidopa+entacapone safe in pregnancy or breastfeeding?+
Safety data in pregnancy and lactation are limited. The product should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Generally, it is avoided during pregnancy and breastfeeding unless specifically advised by a physician.
How do I order Levodopa+carbidopa+entacapone from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and required import documentation.
How does this combination compare with standard levodopa/carbidopa therapy?+
Standard levodopa/carbidopa provides dopamine replacement but has a relatively short plasma half‑life, leading to motor fluctuations. Adding entacapone inhibits COMT, prolonging levodopa exposure, reducing OFF time, and often allowing a lower total levodopa dose. This can improve symptom control and may lessen dyskinesia in some patients.
What are the storage and handling requirements?+
Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the package is tightly closed to maintain product integrity throughout its shelf life.
How is Levodopa+carbidopa+entacapone administered?+
The medication is taken orally, usually with food or a light snack to reduce gastrointestinal irritation. Tablets should be swallowed whole with a full glass of water and not crushed, chewed, or split unless specifically instructed by a healthcare professional.
What are the most serious risks to watch for while taking this drug?+
Serious adverse events include severe liver injury, neuroleptic malignant syndrome, anaphylactic reactions, marked depression or suicidal thoughts, and rare hematologic abnormalities such as neutropenia. Patients should seek immediate medical attention if they experience symptoms like jaundice, high fever, severe rash, mood changes, or unexplained bleeding.
Who should not use Levodopa+carbidopa+entacapone?+
The product is contraindicated in individuals with known hypersensitivity to any component, those currently taking non‑selective MAO inhibitors, patients with severe hepatic impairment, and individuals with a history of neuroleptic malignant syndrome. Caution is also advised for patients with significant cardiovascular disease or uncontrolled psychiatric disorders.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Entacapone, Levodopa, Carbidopa Monohydrate
Route
Oral Use
Manufacturer
Mylan Ireland Limited
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU